Recherche
Enseignement
Solutions
S'identifier
FR
EN - English
CN - 中文
DE - Deutsch
ES - Español
KR - 한국어
IT - Italiano
FR - Français
PT - Português
TR - Turkish
JA - Japanese
Department of Pediatrics,
Center for Genomic Engineering,
Masonic Cancer Center
Joseph J. Peterson has not added Biography.
If you are Joseph J. Peterson and would like to personalize this page please email our Author Liaison for assistance.
SEMA4C is a novel target to limit osteosarcoma growth, progression, and metastasis.
Oncogene Jan, 2020 | Pubmed ID: 31582836
PLX3397 treatment inhibits constitutive CSF1R-induced oncogenic ERK signaling, reduces tumor growth, and metastatic burden in osteosarcoma.
Bone Jul, 2020 | Pubmed ID: 32251854
Implication of ZNF217 in accelerating tumor development and therapeutically targeting ZNF217-induced PI3K-AKT signaling for the treatment of metastatic osteosarcoma.
Molecular cancer therapeutics Sep, 2020 | Pubmed ID: 32999043
University of Minnesota
Kanut Laoharawee1,2,3,
Matthew J. Johnson1,2,3,
Walker S. Lahr1,2,3,
Joseph J. Peterson1,2,3,
Beau R. Webber1,2,3,
Branden S. Moriarity1,2,3
1Department of Pediatrics, University of Minnesota,
2Center for Genomic Engineering, University of Minnesota,
3Masonic Cancer Center, University of Minnesota
Confidentialité
Conditions d'utilisation
Politiques
Contactez-nous
RECOMMANDER À LA BIBLIOTHÈQUE
NEWSLETTERS JoVE
JoVE Journal
Collections de méthodes
JoVE Encyclopedia of Experiments
Archives
JoVE Core
JoVE Business
JoVE Science Education
JoVE Lab Manual
Centre de ressources universitaires
Auteurs
Bibliothécaires
Accès
À PROPOS DE JoVE
Copyright © 2024 MyJoVE Corporation. Tous droits réservés.